We found that the upregulated DEGs were mainly enriched in systemic lupus erythematosus, small cell lung cancer, pyrimidine metabolism, p53 signaling pathway, mismatch repair, and homologous recombination. Here, TP53 is linked to small cell lung carcinoma.